MaraBio and their mission to reduce the severe effects of autism
)
)
In this episode of The Venari Podcast,Michael PauldiscussesMARAbio's mission to mitigate the severe effects of autism.
Leveraging a ground-breaking discovery in immunology, MaraBio aims to detect, treat, and potentially prevent a subtype of autism caused by maternal autoantibodies. Paul shares his journey from research at Harvard Medical School to leading MaraBio, emphasizing the company's focus on precision medicine and the development of diagnostic tests to improve early intervention and outcomes for autism.
Tags:
- The Venari Podcast
- Technology
- Leadership
)
Cristian joined Venari Partners in 2019 and is a core member of the Life Sciences & Healthcare practice. He is hugely passionate about the Digital Health space, and the partner of choice to many emerging and high-growth HealthTech companies across the US & Europe. With over 6 years of experience headhunting global leaders within the Digital Health industry, Cristian helps organisations identify, attract, and retain the best Strategy, Business Development, Operations and Commercial talent around the world. Typical growth scenarios he supports include: - US GTM Expansion for European HealthTech companies - Commercial buildout, due to successful fundraising or product launch (US or EU) - CEO selection to replace a Founder who is looking to transition into a CTO/NED role. - Board level appointments Chairman, non-executive advisory etc. Retained executive recruitment is a core discipline, but the team is also equipped to provide expert Diversity, Equity, and Inclusion (DEI) mapping solutions, Interim & Consulting solutions, Board Advisory, Market Mapping, Compensation Benchmarking, and Leadership & Organisational Assessment. Outside of Venari Partners, as a former chef, he has a tremendous passion for food and loves to experiment with cooking and eating as many different cuisines as possible.
View Full Profile)
)
)
)
)
